Indian Journal of Urology
SYMPOSIUM
Year
: 2014  |  Volume : 30  |  Issue : 3  |  Page : 318--325

Robotic sacrocolpopexy


Teresa L Danforth, Monish Aron, David A Ginsberg 
 Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA

Correspondence Address:
Teresa L Danforth
Department of Urology, Keck School of Medicine, University of Southern California, 1441 Eastlake Avenue, Suite 7416, Los Angeles, California 90089-9178
USA

Pelvic organ prolapse (POP) is a prevalent condition with 1 in 9 women seeking surgical treatment by the age of 80 years. Goals of treatment are relief and prevention of symptoms, and restoration of pelvic floor support. The gold standard for surgical treatment of POP has been abdominal sacrocolpopexy (ASC). However, emerging technologies have allowed for more minimally invasive approach including the use of laparoscopic assisted sacrocolpopexy and robotic assisted sacrocolpopexy (RASC). We performed a PubMed literature search for sacrocolpopexy, «DQ»robotic sacrocolpopexy«DQ» and «DQ»RASC«DQ» and reviewed all retrospective, prospective and randomized controlled trials. The techniques, objective and subjective outcomes and complications are discussed. The most frequent technique involves a polypropylene Y mesh attached to the anterior and posterior walls of the vagina with the single arm attached to the sacrum. Multiple concomitant procedures have been described including hysterectomy, anti-incontinence procedures and concomitant vaginal prolapse repairs. There are few studies comparing RASC to ASC, with the longest follow-up data showing no difference in subjective and objective outcomes. Anatomic success rates have been reported at 79-100% with up to 9% of patients requiring successive surgery for recurrence. Subjective success is poorly defi ned, but has been reported at 88-97%. Most common complications are urinary retention, urinary tract infection, bladder injury and vaginal mucosal injury. Mesh exposure is reported in up to 10% of patients. RASC allows for a minimally invasive approach to treatment of POP with comparable outcomes and low complication rates.


How to cite this article:
Danforth TL, Aron M, Ginsberg DA. Robotic sacrocolpopexy.Indian J Urol 2014;30:318-325


How to cite this URL:
Danforth TL, Aron M, Ginsberg DA. Robotic sacrocolpopexy. Indian J Urol [serial online] 2014 [cited 2020 Jul 9 ];30:318-325
Available from: http://www.indianjurol.com/article.asp?issn=0970-1591;year=2014;volume=30;issue=3;spage=318;epage=325;aulast=Danforth;type=0